Loading...
XHKG2120
Market cap113mUSD
Dec 24, Last price  
12.50HKD
1D
1.13%
1Q
-3.85%
Jan 2017
-63.24%
IPO
-74.54%
Name

Wenzhou Kangning Hospital Co Ltd

Chart & Performance

D1W1MN
XHKG:2120 chart
P/E
9.67
P/S
0.52
EPS
1.21
Div Yield, %
3.66%
Shrs. gr., 5y
0.42%
Rev. gr., 5y
16.43%
Revenues
1.60b
+7.50%
170,813,000226,363,000296,296,000343,674,000415,408,000666,435,528745,971,888860,691,7291,031,283,7601,297,430,3691,484,903,0421,596,265,532
Net income
86m
13,231,00036,193,00051,198,00055,709,00068,832,00049,070,77480,595,67738,227,61855,770,16144,035,995085,947,806
CFO
265m
+16.64%
22,608,00037,078,00033,328,000-5,063,00049,867,00081,498,91966,520,528111,289,774199,655,992193,896,498227,220,564265,033,237
Dividend
Oct 16, 20240.16597 HKD/sh
Earnings
Mar 26, 2025

Profile

Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People's Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services. It is also engaged in pharmaceutical retail. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
IPO date
Nov 19, 2015
Employees
4,652
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,596,266
7.50%
1,484,903
14.45%
1,297,430
25.81%
Cost of revenue
1,286,152
1,239,297
1,048,142
Unusual Expense (Income)
NOPBT
310,114
245,606
249,288
NOPBT Margin
19.43%
16.54%
19.21%
Operating Taxes
12,250
26,574
54,831
Tax Rate
3.95%
10.82%
21.99%
NOPAT
297,864
219,033
194,457
Net income
85,948
 
44,036
-21.04%
Dividends
(32,397)
Dividend yield
3.22%
Proceeds from repurchase of equity
(21,278)
BB yield
2.11%
Debt
Debt current
335,666
252,016
302,291
Long-term debt
912,842
759,434
774,458
Deferred revenue
8,734
9,038
9,342
Other long-term liabilities
108,657
42,405
1
Net debt
618,125
533,692
692,354
Cash flow
Cash from operating activities
265,033
227,221
193,896
CAPEX
(179,732)
Cash from investing activities
(215,017)
Cash from financing activities
96,107
116,178
33,833
FCF
265,928
290,308
(2,247)
Balance
Cash
426,212
281,736
198,735
Long term investments
204,171
196,022
185,660
Excess cash
550,570
403,513
319,523
Stockholders' equity
529,698
432,425
394,523
Invested Capital
2,005,218
1,754,789
1,745,646
ROIC
15.84%
12.51%
11.91%
ROCE
12.01%
11.17%
11.84%
EV
Common stock shares outstanding
74,600
74,600
74,600
Price
13.50
 
21.00
-24.60%
Market cap
1,007,104
 
1,566,606
-23.91%
EV
1,768,370
2,330,976
EBITDA
423,664
359,817
353,873
EV/EBITDA
4.17
6.59
Interest
39,936
45,150
36,268
Interest/NOPBT
12.88%
18.38%
14.55%